LOS ANGELES, CA -- (Marketwired) -- 07/10/13 -- MMRGlobal, Inc. (OTCQB: MMRF) (the "Company") today announced that following its Annual Meeting of Stockholders scheduled for Wednesday, July 17, 2013, the Company will hold an hour-long Q&A Conference Call, on topics unrelated to the Annual Meeting, hosted by Chief Executive Officer Robert H. Lorsch and Chief Financial Officer Ingrid Safranek for investors. The call will start at 1:15 PM Pacific Time / 4:15PM Eastern Time. The Annual Meeting will be held at 10:30AM Pacific Time at MMR's corporate headquarters located at 4401 Wilshire Blvd., Los Angeles, CA, 90010.
According to Bob Lorsch, "There is a lot going on and this type of call is intended to allow stockholders to know about the number of opportunities that we deal with every day. The exciting news is that healthcare professionals are finally being compelled to offer Personal Health Records to their patients as part of their underlying relationship and patient care as a result of Stage 2 Meaningful Use. And based on the Company's patents and other IP, this represents a significant opportunity to open the door to licensing and strategic relationships with vendors and healthcare professionals to utilize our MyMedicalRecords PHRs."
During the live call, interested investors will have the ability to submit questions to management. The Company will be prepared to answer questions pertaining to matters including but not limited to the following:
•The litigation with Walgreen Co., including MMR's plans to seek a stipulation or leave of court to amend its complaint to include claims for infringement of a patent after receiving a June 19th Notice of Allowance for a "Method for Providing a User with a Service for Accessing and Collecting Prescriptions."
•The litigation with Quest Diagnostics, Inc., Jardogs LLC (a wholly owned subsidiary of Allscripts) and/or other similar matters not covered by any confidentiality agreement(s) or litigation privilege.
•Recent positions taken by NEHTA pertaining to MMR's investigation of the possible exploitation of the Company's Australian patents and how it is being dealt with by MMRGlobal's legal team and representatives in Australia as well as MMR's research and investigations in Singapore.
•Licensing opportunities in Japan.
•The status of the Company's Joint Venture with Unis-Tonghe in China.
•The outcome of the recent Surgery Center Management, LLC Appeal in which MMR prevailed and next steps in the case.
•To the extent reasonably possible and subject to existing non-disclosure agreements and understandings, the Company will also answer any questions regarding the status of discussions and negotiations to license its IP to additional EMR vendors including Accenture, which the Company believes participated in the development of electronic and personal medical record systems in Australia and Singapore.
•Sales of MMR's direct-to-consumer products and services, and MMRPro and the continued deliveries of the VISI-MMRPro system pursuant to its agreement with Australian licensee, VisiInc PLC.
Most Popular Stories
- Hezbollah Chief's Assassination Claimed by Sunni Group
- Allstate Seeks to Invest in Minority Firms
- SpaceX's Satellite Launch Is 'Game-Changer'
- Latin Music Conference Turns 25
- U.S. Growth Stayed Steady During Shutdown, Fed Says
- Newtown Massacre Heard on 911 Recordings
- Reid Confident Congress to Pass Immigration Bill
- Guardian Pressured to Stop NSA Stories: Editor
- New Home Sales Shoot up 25 Percent in October
- Climate Change Early Warning System Urged